Aspira Pathlab Live Share Price Today, Share Analysis and Chart

Name: Aspira Pathlab & Diagnostics Ltd.: Is Infosys Ltd. worth buying?
Item: Aspira Pathlab & Diagnostics Ltd.
Rating: 1.98125
Author: Trendlyne DVM scores

Iran war impact

The impact of the Iran-Israel war on Aspira Pathlab & Diagnostics Ltd. (ASPIRA) is categorized as minimal based on the company's geographical presence and business model as detailed in its recent financial disclosures. The company operates pr...

54.75 -3.25 (-5.60%)

32.41% Fall from 52W High

1,802

BSE Volume

High volume+loss today

BSE 27 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Mid Valuation

- / 100

Technically Neutral

39.3 / 100

No estimates available

Aspira Pathlab Live Price Chart

Loading Fundamental data..

Loading data..

Is Aspira Pathlab & Diagnostics Ltd. worth buying?

4 Votes:

Buy 25.0%

Sell 50.0%

Hold 25.0%

Aspira Pathlab Live Share Price Today, Share Analysis and Chart

The impact of the Iran-Israel war on Aspira Pathlab & Diagnostics Ltd. (ASPIRA) is categorized as minimal based on the company's geographical presence and business model as detailed in its recent financial disclosures. The company operates pr...

32.41% Fall from 52W High

High volume+loss today

SWOT Analysis

Aspira Pathlab Live Price Chart